These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 28237815
1. Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy. Tai TY, Warner LN, Jones TD, Jung S, Concepcion FA, Skyrud DW, Fender J, Liu Y, Williams AD, Neumaier JF, D'Ambrosio R, Poolos NP. Neuroscience; 2017 May 04; 349():35-47. PubMed ID: 28237815 [Abstract] [Full Text] [Related]
2. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism. Muniyappa H, Das KC. Cell Signal; 2008 Apr 04; 20(4):675-83. PubMed ID: 18222647 [Abstract] [Full Text] [Related]
3. Effect of ulinastatin on myocardial ischemia-reperfusion injury through JNK and P38 MAPK signaling pathways. Yang ZH, Lu YJ, Gu KP, Xiang ZY, Huang HM. Eur Rev Med Pharmacol Sci; 2019 Oct 04; 23(19):8658-8664. PubMed ID: 31646600 [Abstract] [Full Text] [Related]
4. p38 Mitogen-activated protein kinase and c-Jun NH2-terminal protein kinase regulate the accumulation of a tight junction protein, ZO-1, in cell-cell contacts in HaCaT cells. Minakami M, Kitagawa N, Iida H, Anan H, Inai T. Tissue Cell; 2015 Feb 04; 47(1):1-9. PubMed ID: 25435485 [Abstract] [Full Text] [Related]
5. The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase. Croons V, Martinet W, Herman AG, Timmermans JP, De Meyer GR. J Pharmacol Exp Ther; 2009 Jun 04; 329(3):856-64. PubMed ID: 19286921 [Abstract] [Full Text] [Related]
6. SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes. Henklova P, Vrzal R, Papouskova B, Bednar P, Jancova P, Anzenbacherova E, Ulrichova J, Maurel P, Pavek P, Dvorak Z. Eur J Pharmacol; 2008 Sep 28; 593(1-3):16-23. PubMed ID: 18655782 [Abstract] [Full Text] [Related]
7. c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1. Cho JE, Park S, Cho SN, Lee H, Kim YS. BMB Rep; 2012 Oct 28; 45(10):583-8. PubMed ID: 23101513 [Abstract] [Full Text] [Related]
8. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways. Leo V, Stefanachi A, Nacci C, Leonetti F, de Candia M, Carotti A, Altomare CD, Montagnani M, Cellamare S. J Pharm Pharmacol; 2015 Oct 28; 67(10):1380-92. PubMed ID: 26078032 [Abstract] [Full Text] [Related]
9. Olaquindox-induced apoptosis is suppressed through p38 MAPK and ROS-mediated JNK pathways in HepG2 cells. Zhao WX, Tang SS, Jin X, Zhang CM, Zhang T, Wang CC, Sun Y, Xiao XL. Cell Biol Toxicol; 2013 Aug 28; 29(4):229-38. PubMed ID: 23812630 [Abstract] [Full Text] [Related]
10. In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity. Lirk P, Haller I, Colvin HP, Lang L, Tomaselli B, Klimaschewski L, Gerner P. Anesth Analg; 2008 May 28; 106(5):1456-64, table of contents. PubMed ID: 18420860 [Abstract] [Full Text] [Related]
11. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation. Chen LW, Chen PH, Chang WJ, Wang JS, Karin M, Hsu CM. Crit Care Med; 2007 May 28; 35(5):1332-40. PubMed ID: 17414734 [Abstract] [Full Text] [Related]
12. Pro-life role for c-Jun N-terminal kinase and p38 mitogen-activated protein kinase at rostral ventrolateral medulla in experimental brain stem death. Chang AY. J Biomed Sci; 2012 Nov 17; 19(1):96. PubMed ID: 23157661 [Abstract] [Full Text] [Related]
13. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX, Kong CZ. Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842 [Abstract] [Full Text] [Related]
14. Puerarin reduces apoptosis in rat hippocampal neurons culturea in high glucose medium by modulating the p38 mitogen activated protein kinase and c-Jun N-terminal kinase signaling pathways. Xu X, Wang J, Zhang H, Tian G, Liu Y. J Tradit Chin Med; 2016 Feb 22; 36(1):78-84. PubMed ID: 26946623 [Abstract] [Full Text] [Related]
15. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60. Kikuchi H, Yuan B, Yuhara E, Takagi N, Toyoda H. Int J Oncol; 2013 Dec 22; 43(6):2046-56. PubMed ID: 24064676 [Abstract] [Full Text] [Related]
16. Activation of c-Jun N-terminal kinase by Akabane virus is required for apoptosis. Mitomo S, Omatsu T, Tsuchiaka S, Nagai M, Furuya T, Mizutani T. Res Vet Sci; 2016 Aug 22; 107():147-151. PubMed ID: 27473988 [Abstract] [Full Text] [Related]
17. Low concentrations of nitric oxide (NO) induced cell death in PC12 cells through activation of p38 mitogen-activated protein kinase (p38 MAPK) but not via extracellular signal-regulated kinases (ERK1/2) or c-Jun N-terminal protein kinase (JNK). Yamamoto T, Yuyama K, Yamamoto H. Neurosci Lett; 2006 Jan 16; 392(3):170-3. PubMed ID: 16198052 [Abstract] [Full Text] [Related]
18. Down-regulation of aquaporin3 expression by lipopolysaccharide via p38/c-Jun N-terminal kinase signalling pathway in HT-29 human colon epithelial cells. Li FX, Huang LZ, Dong C, Wang JP, Wu HJ, Shuang SM. World J Gastroenterol; 2015 Apr 21; 21(15):4547-54. PubMed ID: 25914463 [Abstract] [Full Text] [Related]
19. Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways. Ito S, Ozawa K, Zhao J, Kyotani Y, Nagayama K, Yoshizumi M. J Pharmacol Sci; 2015 Jan 21; 127(1):69-74. PubMed ID: 25704021 [Abstract] [Full Text] [Related]